OKUR Stock Analysis: Buy, Sell, or Hold?
OKUR - OnKure Therapeutics, Inc. Class A Common Stock
$4.29
0.22 (5.41%)
▲
5d:
-6.54%
30d:
+35.33%
90d:
+47.93%
HOLD
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 05, 2026
29d
Get Alerted When OKUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OKUR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OKUR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OKUR is currently trading at $4.29, which is considered slightly high relative to its 30-day fair value range of $2.70 to $4.01.
Technical Outlook: Technically, OKUR is in a uptrend. Immediate support is located at $3.58, while resistance sits at $4.75. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.20 (+394.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OKUR is in a uptrend. Immediate support is located at $3.58, while resistance sits at $4.75. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.20 (+394.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.70 -
$4.01
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- BULLISH: Trading 394.2% below Wall St target ($21.20)
- CAUTION: Recommendation downgraded due to -6.5% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.70 -
$4.01
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.58
Resistance Level
$4.75
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.09
Wall Street Target
$21.20
(+394.2%)
Share & Embed Analysis
Last updated: April 05, 2026 12:07 PM ET
Data refreshes hourly during market hours. Next update: 1:07 PM
Data refreshes hourly during market hours. Next update: 1:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OKUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Jason A Leverone
SELL
302 shares
2025-12-22
Nicholas A Saccomano
SELL
87 shares
2025-12-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
